Mannkind (MNKD) EBITDA Margin (2011 - 2026)
Mannkind (MNKD) posted EBITDA Margin of 5.53% for Q2 2026, down 4.12 percentage points from 9.65% a year earlier but up 0.30 percentage points from the prior quarter.
Powered by 
Analysis
Mannkind (MNKD) EBITDA Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Mannkind was 7.64%, down 17.32 percentage points year-over-year; for FY2025, it was 14.64%, down 13.37 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +84.89 percentage points (FY2020 to FY2025).
- In prior years, Mannkind's EBITDA Margin was 28.01% in FY2024 (+21.36 pp), 6.64% in FY2023 (+67.57 pp), -60.93% in FY2022 (-1.23 pp) and -59.70% in FY2021 (+10.55 pp).
- Quarterly EBITDA Margin has run from a low of -199.58% in Q4 2021 to a high of 37.32% in Q4 2024 over five years.
- On a year-over-year basis, EBITDA Margin has declined in each of the last three quarters, with an average year-over-year change of -5.67 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2022, with a gain of 166.93 percentage points; the weakest was Q1 2022, with a drop of 140.51 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 5.23% (Q1 2026), -1.48% (Q4 2025) and 25.52% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Mannkind | 1.04 Bn | 358.85 Mn | 94.97 Mn | 5.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.53% |
| Mar 31, 2026 | 5.23% |
| Dec 31, 2025 | -1.48% |
| Sep 30, 2025 | 25.52% |
| Jun 30, 2025 | 9.65% |
| Mar 31, 2025 | 31.14% |
| Dec 31, 2024 | 37.32% |
| Sep 30, 2024 | 21.23% |
| Jun 30, 2024 | 25.34% |
| Mar 31, 2024 | 27.29% |
| Dec 31, 2023 | 15.53% |
| Sep 30, 2023 | 11.96% |
| Jun 30, 2023 | 6.05% |
| Mar 31, 2023 | -12.16% |
| Dec 31, 2022 | -32.65% |
| Sep 30, 2022 | -26.28% |
| Jun 30, 2022 | -104.41% |
| Mar 31, 2022 | -172.26% |
| Dec 31, 2021 | -199.58% |
| Sep 30, 2021 | -23.71% |
API Access
Mannkind EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MNKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MNKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MNKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();